FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

39703511000001108: Ruxolitinib 5mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1817151000001115 Ruxolitinib 5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1817161000001117 Ruxolitinib 5mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib 5mg tablets Is a Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Is a Product containing ruxolitinib false Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a True Ruxolitinib 5mg tablets Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets 60 tablet Has VMP True Ruxolitinib 5mg tablets Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets 56 tablet Has VMP True Ruxolitinib 5mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start